Connect with us

Technology

Duoning Biotech announced strategic partnership with Branca Bunús to promote the next generation of transfection reagents

Published

on

SHANGHAI, Nov. 5, 2024 /PRNewswire/ — Duoning Biotechnology Group (“Duoning”) announced a strategic partnership agreement with Branca Bunús Ltd. (“Branca Bunús”). Under this agreement, the two companies will collaborate on the development, optimization, and application of transfection reagents, with the goal of providing  biopharmaceutical customers with innovative transfection reagents through resource sharing, thereby enhancing the efficiency of biopharmaceutical development in upstream bioprocess.

Branca Bunús is a gene delivery technology company based in Ireland, specializing in the development of safe gene delivery vectors and effective transfection reagents derived from unique cationic polymer materials. Guided by a product development philosophy that emphasizes high efficiency, biocompatibility, and significant clinical and industrial application value, Branca Bunús has created the BrPERfect® series of transfection reagents. The company also offers supporting services, including the development of targeted gene delivery vectors and directional optimization. As a well-established one-stop bioprocess solution provider in China, Duoning Biotech’s offerings encompass the entire bioprocess workflow, from upstream cell culture to downstream filtration and purification. Additionally, Duoning Biotech provides services such as media production, process optimization, and validation testing.

After the cooperation is established, Branca Bunús will be responsible for the research, development, and performance enhancement of transfection reagents. This includes scientific research applications involving DNA, siRNA, and mRNA transfection, as well as the production of recombinant proteins, AAV, and LV based on the transient transfection of CHO and HEK 293 cells. Duoning will leverage its established sales network and collaborative sales strategy for upstream process products to comprehensively promote this solution. Additionally, both parties will form a specialized research and marketing team to optimize the transient transfection process by examining the interaction principles of transfection reagents and cell culture media. They will also conduct market research to develop a comprehensive solution for the application of transfection reagents.

Hongfeng Gu, Vice President of Duoning, stated, “Branca Bunús is an emerging biotechnology company that has developed a leading hyperbranched polymer gene delivery vector platform, founded by Professor Wenxin Wang. We are honored to collaborate with companies that possess core technologies. The BrPERfect® series of transfection reagents from Branca Bunús, combined with Duoning’s cell culture media, bioreactors, and other products, will offer customers more comprehensive upstream bioprocessing solutions.”

Dr. Zhonglei He, Chief Technology Officer of Branca Bunús, stated, “The significant contribution of Duoning to the rapid development of the biotechnology market is evident to all. We are honored to collaborate with Duoning, particularly in its one-stop bioprocessing solutions. Our goal is to provide efficient and stable transfection reagent products and process support, ensuring timely and high-quality products and services for various R&D and production applications, including transient protein production and screening in downstream processes, stem cell enhancement, and the production of diverse viral vectors through transient transfection.”

About Duoning

Shanghai Duoning Biotechnology Co., Ltd. (“Duoning”) is a leading one-stop bioprocess solutions provider in China, committed to offering products and services required for the discovery, development and commercialization production of biologics, including reagents, consumables, instruments, equipment, and validation services. Leveraging our integrated bioprocess system, we empower our partners to achieve effective, reliable, lower-cost and higher-quality biologics production processes. For more information, please visit: www.duoningbio.com/en

For media inquiries, please contact: PR@duoningbio.com 

About Branca Bunús

Branca Bunús is an emerging Irish biotechnology company specializing in innovative gene delivery technologies. Leveraging over a decade of research by its founding technical team, the company focuses on the development and production of advanced gene delivery vectors and transfection reagents. Branca Bunús aims to provide cost-effective, high-yield transient transfection solutions, along with supporting services such as targeted gene delivery vector development and directional optimization. The company is dedicated to transforming groundbreaking discoveries into life-changing practical applications. To learn more, please visit: http://brancabunus.com

View original content:https://www.prnewswire.com/news-releases/duoning-biotech-announced-strategic-partnership-with-branca-bunus-to-promote-the-next-generation-of-transfection-reagents-302297073.html

SOURCE Duoning

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

ZICC: Internet Experts Pay Attention to the Development of Artificial Intelligence

Published

on

By

BEIJING, Nov. 23, 2024 /CNW/ — During the Wuzhen Summit of the World Internet Conference, ZICC interviewed Internet experts from all over the world.

Lampros Sterg, UNESCO Chair in AI & Data Science, said that AI can accelerate social progress, but it needs to be used properly to avoid its negative effects in order to benefit citizens and society. Latif Ladid, the president of the IPv6 Forum, called for the establishment of a global governance system to allow artificial intelligence technology to serve humanity for good. South Korean computer scientist Kilnam Chon shared insights on AI’s positive role in healthcare. He urged global efforts to ensure AI safety and prevent its misuse in weapons. Indian entrepreneur Bibin Babu said he believes that AI will not replace humans, but will create more new jobs.

View original content to download multimedia:https://www.prnewswire.com/news-releases/zicc-internet-experts-pay-attention-to-the-development-of-artificial-intelligence-302314745.html

SOURCE ZICC

Continue Reading

Technology

Hankyung.com introduces: MecKare, Leading the AI-powered Innovation in Health Monitoring Solution

Published

on

By

– Leading efficient care management for the elderly with unimpeded smartcare

https://img.hankyung.com/pdsdata/pr.hankyung.com/uploads/2024/11/image01-1.png

SEOUL, South Korea, Nov. 23, 2024 /PRNewswire/ — JCF Technology is a startup that independently developed ‘MecKare’, a radar sensor that measures biological signals in a non-contact manner, and provides a platform service that automatically connects users and guardians in two-way emergency situations through an artificial intelligence analysis system. Since its establishment in 2016, it has developed a highly accurate non-contact multi-biological radar sensor through many years of technology accumulation, and succeeded in commercializing the product for the first time in 2021.

MecKare uses microwave radar and micro-Doppler signal processing technology to measure the user’s heart rate, respiratory rate, and skin temperature within 16.4 ft in real time. The sensor can measure human body movement patterns using precise and highly responsive thermal infrared rays and can detect falls through pattern analysis based on changes in human movement. In particular, the movement and change of thermal infrared rays within the measurement range are detected in real time, and the trend of biomarkers that appear as advance signs before a person falls can be checked through differential motion detection that measures the user’s movement pattern. It provides an alarm in advance by predicting before a person falls, enabling accuracy and quick response to accidents. As a result, it is possible to prevent safety accidents in the elderly by detecting emergency situations such as lonely death, cardiac arrest, breathing difficulties, and falls. Additionally, unlike other existing wearable devices such as smart watches or bands, MecKare does not need to be worn or attached to the body, so it can be used remotely via Wi-Fi without causing stress to the user.

https://img.hankyung.com/pdsdata/pr.hankyung.com/uploads/2024/11/image02.png

MecKare can be installed in the bedroom, bathroom, living room, or entrance of a home or facilities(Assisted Living, Nursing Home, etc) to provide 24-hour monitoring without a camera and detect abnormal signs in advance using a biometric information analysis algorithm and deliver them to the guardian.

MecKare’s radar biometric sensor is recognized in the global market for its technology as a device that obtains precisely customized biometric information while overcoming spatial constraints and without risk of privacy infringement. MecKare is being supplied to senior care facilities in Australia, Germany, Poland, Saudi Arabia, and China. In 2025, MecKare plans to conduct verification of vital signs such as attendance, fall prevention, and asthma of elderly people living in hospitals or assisted living in conjunction with local PPOs/HMOs in the United States.

In summary, MecKare is a system that reduces user inconvenience and enables management of multiple patients. By being able to provide personalized health data analysis results, it will serve as an opportunity to change the market paradigm towards preventive smart care. We expect MecKare’s A.I to play a role as an innovator that complements, rather than replaces, humans in care settings.

View original content:https://www.prnewswire.com/news-releases/hankyungcom-introduces-meckare-leading-the-ai-powered-innovation-in-health-monitoring-solution-302310743.html

SOURCE Hankyung.com

Continue Reading

Technology

SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2

Published

on

By

ZHONGSHAN, China, Nov. 23, 2024 /PRNewswire/ — SUNLU was present at the Formnext 2024, the largest event for additive manufacturing held in Germany, where they unveiled the new product FilaDryer E2.

SUNLU, the Chinese Tech Giant in the 3D printing industry, recently wrapped up a highly successful showcase at Formnext 2024, one of the largest events for additive manufacturing held in Frankfurt, Germany from November 19–22. SUNLU’s booth (F29, Hall 11.1) hosted a large number of visitors eager to explore the company’s latest innovations in 3D printing materials, equipment, and technology.

A key highlight of SUNLU’s exhibit was the new range of functional filaments, including PA6-CF, PA12-CF, PC-ABS, and PETG-CF. The filaments provide enhanced strength, durability, and temperature resistance, catering to more demanding applications in both industrial and personal use. Visitors saw firsthand how these materials impact the quality, resilience and overall performance of 3D-printed parts.

The debut of the SUNLU FilaDryer E2 also attracted significant interest for its powerful features, notably its maximum drying temperature of 110°C, which allows for the fast drying of functional filaments and annealing printed parts to improve their strength and durability. The FilaDryer E2 will be available for preorder on January 8, 2025, on our official website. Visitors expressed great anticipation, after seeing the upgrades that set the FilaDryer E2 apart. Jack Jiang, the founder of SUNLU, said: “This opportunity allowed us to position and showcase SUNLU as one of the key global players in the 3D Industry.”

Formnext 2024 was a valuable opportunity for SUNLU to connect with peers, partners, and customers worldwide. The team exchanged ideas with industry professionals and distributors, where the company had the opportunity to interview James Rooke from “Honey Badger Print and Paint” and talk about the new SUNLU’s Filament Connector FC01 and it’s perks to make the most out of leftover materials, while enabling multi-color prints.

As the exhibition comes to an end, the SUNLU team extends heartfelt thanks to everyone who visited the booth and made the event memorable, and the company looks forward to meeting up again next year for groundbreaking solutions and meaningful partnerships within the additive manufacturing community.

About SUNLU 

Founded in 2013, SUNLU is a leading 3D printing materials company specializing in R&D, manufacturing, and sales. With facilities in China and Vietnam, we operate 150+ automated production lines and employ over 900 staff. Our certified products serve customers across Europe, America, and Southeast Asia. 

SUNLU has led 30+ research projects, secured 400+ patents, and introduced innovations like “Neat Winding” filament, 3D printing drying boxes, and the ±0.02mm FDM filament tolerance standard, enhancing precision and user experience. 

Guided by our mission, “Simply Your Creation,” we empower creators worldwide with reliable 3D printing materials.

For more information, please visit
https://www.sunlu.com.

Media Contact:
Branding@sunlu.com  
Sales@sunlu.com  

Stay Updated:
If you’re interested in the FilaDryer E2, sign up here to receive exclusive preorder information and updates directly in your inbox.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sunlu-formnext-2024-event-highlights-from-functional-filaments-to-filadryer-e2-302314231.html

SOURCE SUNLU

Continue Reading

Trending